Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Medical University of Lublin, Chodźki 4a, 20093 Lublin, Poland.
Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 160, 2100 Copenhagen, Denmark.
Biomolecules. 2023 Sep 5;13(9):1349. doi: 10.3390/biom13091349.
This study reports on the synthesis and evaluation of novel compounds replacing the nitrogen-containing heterocyclic ring on the chemical backbone structure of cytochrome P450 17α-hydroxylase/12,20-lyase (CYP17A1) inhibitors with a phenyl bearing a sulfur-based substituent. Initial screening revealed compounds with marked inhibition of CYP17A1 activity. The selectivity of compounds was thereafter determined against cytochrome P450 21-hydroxylase, cytochrome P450 3A4, and cytochrome P450 oxidoreductase. Additionally, the compounds showed weak inhibitory activity against aldo-keto reductase 1C3 (AKR1C3). The compounds' impact on steroid hormone levels was also assessed, with some notable modulatory effects observed. This work paves the way for developing more potent dual inhibitors specifically targeting CYP17A1 and AKR1C3.
本研究报告了新型化合物的合成和评价,这些化合物用带有硫取代基的苯基替代细胞色素 P450 17α-羟化酶/12,20-裂合酶(CYP17A1)抑制剂的化学主链结构上含氮杂环,初步筛选显示出对 CYP17A1 活性有明显抑制作用的化合物。此后,对化合物对细胞色素 P450 21-羟化酶、细胞色素 P450 3A4 和细胞色素 P450 氧化还原酶的选择性进行了测定。此外,这些化合物对醛酮还原酶 1C3(AKR1C3)也表现出较弱的抑制活性。还评估了化合物对甾体激素水平的影响,观察到一些显著的调节作用。这项工作为开发专门针对 CYP17A1 和 AKR1C3 的更有效的双重抑制剂铺平了道路。